Vitamin D for your patients with chronic hepatitis C?

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Vitamin D metabolism and physiologic effects at target organs
Volume 59, Issue 6, Pages (December 2013)
m-TOR inhibitors: What role in liver transplantation?
m-TOR inhibitors: What role in liver transplantation?
Volume 68, Issue 5, Pages (May 2018)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Role of vitamin D in uterine fibroid biology
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Vitamin D for your patients with chronic hepatitis C?
Vitamin D: The Iceberg Nutrient
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Volume 42, Issue 6, Pages (June 2005)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
miR-122 – A key factor and therapeutic target in liver disease
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
m-TOR inhibitors: What role in liver transplantation?
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Vitamin D for your patients with chronic hepatitis C? Adeeb H. Rahman, Andrea D. Branch  Journal of Hepatology  Volume 58, Issue 1, Pages 184-189 (January 2013) DOI: 10.1016/j.jhep.2012.07.026 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Vitamin D is obtained from dietary sources and through the photochemical conversion of 7-dehydrocholesterol in the skin. It binds to vitamin D-binding protein and is transported to the liver, where it is hydroxylated by 25-hydroxylases to form 25(OH)D, a stable metabolite that is the best single indicator of vitamin D status. A second hydroxylation step, mediated by the 1a-hydroxylase CYP27B1 in the kidneys and other extrarenal tissues, produces the most active metabolite 1,25(OH)2D, which signals primarily through the VDR, resulting in pleiotropic physiological effects, as highlighted in the Fig. 1,25(OH)2D is catabolized by CPY24A1 to its inactive metabolite, calcitroic acid. Journal of Hepatology 2013 58, 184-189DOI: (10.1016/j.jhep.2012.07.026) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2013 58, 184-189DOI: (10. 1016/j. jhep. 2012. 07 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions